[HTML][HTML] Role of p53 in breast cancer progression: an insight into p53 targeted therapy

C Marvalim, A Datta, SC Lee - Theranostics, 2023 - ncbi.nlm.nih.gov
The transcription factor p53 is an important regulator of a multitude of cellular processes. In
the presence of genotoxic stress, p53 is activated to facilitate DNA repair, cell cycle arrest …

p53 regulation of DNA excision repair pathways

ML Smith, YR Seo - Mutagenesis, 2002 - academic.oup.com
The regulation of DNA excision repair pathways by p53 and its downstream genes is an
emerging body of literature, largely distinct and separable from the more-studied cell cycle …

Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1

S Pervin, R Singh, G Chaudhuri - Proceedings of the …, 2001 - National Acad Sciences
DETA-NONOate, a nitric oxide (NO) donor, induced cytostasis in the human breast cancer
cells MDA-MB-231, and the cells were arrested in the G1 phase of the cell cycle. This …

[HTML][HTML] A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer

CX Ma, MJC Ellis, GR Petroni, Z Guo, S Cai… - Breast cancer research …, 2013 - Springer
Mutations in TP53 lead to a defective G1 checkpoint and the dependence on checkpoint
kinase 1 (Chk1) for G2 or S phase arrest in response to DNA damage. In preclinical studies …

Genealogy, expression, and molecular mechanisms in apoptosis

Z Dlamini, Z Mbita, M Zungu - Pharmacology & therapeutics, 2004 - Elsevier
Apoptosis, known as programmed cell death, is a conserved, gene-directed mechanism for
the elimination of unnecessary or unwanted cells from an organism. A retrospective look at …

[HTML][HTML] A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies

PM Fracasso, KJ Williams, RC Chen, J Picus… - Cancer chemotherapy …, 2011 - Springer
Abstract Purpose UCN-01 (7-hydroxystaurosporine) is a multi-targeted protein kinase
inhibitor that exhibits synergistic activity with DNA-damaging agents in preclinical studies …

Inhibitors of cyclin-dependent kinase modulators for cancer therapy

AM Senderowicz - Advances in Targeted Cancer Therapy, 2005 - Springer
Upon activation of mitogenic signaling cascades, cells commit to entry into a series of
regulated steps allowing traverse of the cell cycle. Synthesis of DNA (genome duplication) …

Progesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA

VCL Lin, R Jin, PH Tan, SE Aw, CT Woon… - The American journal of …, 2003 - Elsevier
Progesterone is an important regulator of growth and differentiation in breast tissues. In this
study, the effect of progesterone on cell differentiation was evaluated in the estrogen …

[图书][B] Inhibitors of cyclin-dependent kinases as anti-tumor agents

PJ Smith, EW Yue - 2006 - taylorfrancis.com
One of the few books to cover all aspects of cyclin-dependent kinases (CDKs), Inhibitors of
Cyclin-dependent Kinases as Anti-tumor Agents provides an overview of CDKs as molecular …

An enzyme-linked immunosorbent assay to screen for inhibitors of the oncogenic anaplastic lymphoma kinase

RH Gunby, CJ Tartari, F Porchia… - …, 2005 - haematologica.org
The discovery of novel anti-cancer drugs targeting anaplastic lymphoma kinase (ALK), an
oncogenic tyrosine kinase, raises the need for in vitro assays suitable for screening …